Valantine Hannah
- SEC CIK
- 0001855608
In the past year, 6 open-market sale filings worth $5.69M and no purchases.
Current role at each company
- CDNA CareDx, Inc.Directoras of Jul 17, 2026
- BBIO BridgeBio Pharma, Inc.Directoras of Jun 24, 2026
- PACB Pacific Biosciences of California, Inc.Directoras of Jun 4, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $5.69M
- 6 filings
- Net
- −$5.69M
- Bought minus sold
- Companies
- 2
- With open-market trades
Trades
Every Form 4 that lists Valantine Hannah as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
CDNA CareDx, Inc.
Director3 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 23, 2025 (view filing) | Jun 18 | 5 days | Valantine HannahDirector | SSale | −10.6K | $19.16 | −$202.5K | −21.3%39.0K after | 10b5-1 |
| Jun 16, 2026 (view filing) | Jun 15 | 1 day | Valantine HannahDirector | SSale | −12.1K | $23.11 | −$279.7K | −24.8%36.7K after | 10b5-1 |
| Jul 17, 2026 (view filing)4:22 PM ET | Jul 16 | 1 day | Valantine HannahDirector | SSale | −28.8K | $36.15 | −$1.04M | −44.0%36.7K after | 2 lots10b5-1 |
BBIO BridgeBio Pharma, Inc.
Director15 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 17, 2023 (view filing) | Nov 15 | 2 days | Valantine HannahDirector | SSale | −2.92K | $30.00 | −$87.5K | −62.3%1.76K after | 10b5-1 |
| Dec 19, 2023 (view filing) | Dec 15 | 4 days | Valantine HannahDirector | SSale | −2.92K | $36.12 | −$105.3K | −62.3%1.76K after | 10b5-1 |
| Jan 18, 2024 (view filing) | Jan 16 | 2 days | Valantine HannahDirector | SSale | −2.92K | $37.97 | −$110.7K | −62.3%1.76K after | 10b5-1 |
| Feb 20, 2024 (view filing) | Feb 15 | 5 days | Valantine HannahDirector | SSale | −2.92K | $37.75 | −$110.0K | −62.3%1.76K after | 10b5-1 |
| Mar 10, 2025 (view filing) | Mar 6 | 4 days | Valantine HannahDirector | SSale | −12.9K | $32.58 | −$419.5K | −87.9%1.76K after | 10b5-1 |
| Jun 11, 2025 (view filing) | Jun 10 | 1 day | Valantine HannahDirector | SSale | −4.29K | $40.00 | −$171.7K | −70.9%1.76K after | 10b5-1 |
| Jun 30, 2025 (view filing) | Dec 28, 2021 | 1,280 days | Valantine HannahDirector | PPurchase | +1.54K | $12.68 | +$19.6K | New position1.54K after | Amended |
| Jun 30, 2025 (view filing) | Dec 28, 2021 | 1,280 days | Valantine HannahDirector | PPurchase | +796 | $13.16 | +$10.5K | +42.1%2.69K after | Amended |
| Jun 30, 2025 (view filing) | Dec 29, 2021 | 1,279 days | Valantine HannahDirector | PPurchase | +1.75K | $14.24 | +$24.9K | +113.6%3.29K after | Amended |
| Jun 30, 2025 (view filing) | Jun 26 | 4 days | Valantine HannahDirector | SSale | −2.42K | $44.05 | −$106.5K | −24.5%7.46K after | 2 lots |